Gothenburg University, RISE and Iscaffpharma received the prestigious grant support and are partnering with AstraZeneca (LSE/STO/Nasdaq: AZN), for a project to develop synthetic 3D-models that recapitulate the tumour microenvironment for cancer drug discovery.
Read MorePrevious participants usually mention the knowledge exchange with the other group members as an important and rewarding part of the education. This year's class members represent a handful of nationalities, business experience from a dozen countries across five continents and a high level of seniority. The participants come from a wide range of organisations including AstraZeneca, CEVT, the Port of Gothenburg, MobilityXlab, Oatly and SecureBug.
Read More